WCM Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
WCM Investment Management's CRL Position: Q1 2026 in Review
WCM Investment Management sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 102,234 shares — an estimated $20.6M sold.
WCM Investment Management first reported a position in CRL in Q1 2019 and held it in 14 quarters. The position peaked at $20.6M in Q4 2025. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2026.
- WCM Investment Management reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
- WCM Investment Management sold 102,234 Charles River Laboratories shares in Q1 2026, an estimated $20.6M.
- WCM Investment Management first reported a position in Charles River Laboratories in Q1 2019 and held it in 14 quarters.
- WCM Investment Management's Charles River Laboratories position peaked at $20.6M in Q4 2025.
- 560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.
Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.